Owlet (OWLT) Gains from Investment Securities (2020 - 2021)
Owlet (OWLT) posted quarterly Gains from Investment Securities of $970000.0 for Q2 2021, down 78.95% quarter-over-quarter from $4.6 million in Q1 2021.
Owlet (OWLT) Gains from Investment Securities (2020 - 2021) Analysis & Trends
Owlet (OWLT) has reported Gains from Investment Securities for 2 consecutive years, with $970000.0 the latest figure, recorded in Q2 2021.
- In Q2 2021, Gains from Investment Securities changed N/A year-over-year to $970000.0; the TTM figure through Mar 2022 stood at $970000.0 (changed N/A YoY), while the FY2021 annual figure was $5.6 million, up 185.76% from the prior year.
- Gains from Investment Securities declined to $970000.0 in Q2 2021 per OWLT's latest filing, from $4.6 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $7.2 million in Q4 2020 and bottomed at $1000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn |
| 10 | Owlet | 161.60 Mn | 125.05 Mn | 21.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 970,000.00 |
| Jun 30, 2021 | 970,000.00 |
| Mar 31, 2021 | 4.61 Mn |
| Mar 31, 2021 | 4.61 Mn |
| Dec 31, 2020 | 7.24 Mn |
| Dec 31, 2020 | 7.24 Mn |
| Sep 30, 2020 | 1,000.00 |
| Sep 30, 2020 | 1,000.00 |